Skip to main content

Kronox Lab Sciences Ltd

NSE: KRONOX BSE: 544187

Incorporated in 2008, Kronox Lab Sciences Ltd manufactures High Purity Fine, inorganic chemicals, phosphate, and metallic chemicals[1]

129
52W: ₹96 — ₹207
PE 18.5 · Book ₹27.3 · +373% vs book
Market Cap₹479 Cr
Stock P/E18.5Price to Earnings
ROCE43.8%Return on Capital
ROE32.6%Return on Equity
Div. Yield0.41%Face Value ₹10

Strengths

  • +Company is almost debt free.
  • +Company has delivered good profit growth of 24.3% CAGR over last 5 years
  • +Company has a good return on equity (ROE) track record: 3 Years ROE 35.9%

Shareholding Pattern

Promoters74.21%
FIIs0.08%
DIIs2.05%
Public23.66%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters74.21%74.21%74.21%74.21%74.21%74.21%74.21%74.21%
FIIs1.56%0.56%1.00.49%0.10.05%0.40.03%0.00.03%0.05%0.00.08%0.0
DIIs4.34%2.57%1.82.2%0.42.2%1.71%0.51.93%0.22%0.12.05%0.0
Public19.89%22.66%2.823.1%0.423.54%0.424.04%0.523.84%0.223.74%0.123.66%0.1

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales21.0220.7122.1825.1924.8624.0126.1324.2925.5325.27
Expenses15.1614.6314.3316.9816.0615.6518.3816.3216.8817.24
Operating Profit5.866.087.858.218.88.367.757.978.658.03
OPM %27.88%29.36%35.39%32.59%35.4%34.82%29.66%32.81%33.88%31.78%
Net Profit4.354.745.886.156.476.536.326.286.686.59
EPS ₹1.171.281.581.661.741.761.71.691.81.78

AI Insights

Revenue Trend

TTM revenue at ₹101Cr, up 1% YoY. OPM at 32%.

Debt Position

Borrowings at ₹3Cr. Debt-to-equity ratio: 0.05x. Healthy balance sheet.

Capex Cycle

CWIP at ₹1Cr (3% of fixed assets). Moderate ongoing capital expenditure.

Institutional Flow

DIIs: 2.05% (-2.29pp change). FIIs: 0.08% (-1.48pp change). Promoters hold 74.21%.

Margin & Efficiency

ROCE improving from 0% (Mar 2020) to 44% (Mar 2025). Working capital days: 168.

Valuation

PE 18.5x with 43.8% ROCE. Price is 373% above book value of ₹27.3. Dividend yield: 0.41%.

Recent Announcements